AptaBio Therapeutics Financials
| 293780 Stock | 6,280 80.00 1.26% |
AptaBio |
Understanding current and past AptaBio Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AptaBio Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in AptaBio Therapeutics' assets may result in an increase in income on the income statement.
Please note, the presentation of AptaBio Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AptaBio Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of AptaBio Therapeutics' management manipulating its earnings.
| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7293780003 |
| Business Address | Tower 504, 13, |
| Industry | Biotechnology & Medical Research |
| Benchmark | Dow Jones Industrial |
| Website | www.aptabio.com |
| Phone | 82 70 7152 0097 |
You should never invest in AptaBio Therapeutics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of AptaBio Stock, because this is throwing your money away. Analyzing the key information contained in AptaBio Therapeutics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
AptaBio Therapeutics Key Financial Ratios
AptaBio Therapeutics' financial ratios allow both analysts and investors to convert raw data from AptaBio Therapeutics' financial statements into concise, actionable information that can be used to evaluate the performance of AptaBio Therapeutics over time and compare it to other companies across industries.| Return On Equity | -17.47 | |||
| Return On Asset | -0.0568 | |||
| Beta | 2.39 |
AptaBio Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AptaBio Therapeutics's current stock value. Our valuation model uses many indicators to compare AptaBio Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AptaBio Therapeutics competition to find correlations between indicators driving AptaBio Therapeutics's intrinsic value. More Info.AptaBio Therapeutics is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value AptaBio Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AptaBio Therapeutics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.AptaBio Therapeutics Systematic Risk
AptaBio Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. AptaBio Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on AptaBio Therapeutics correlated with the market. If Beta is less than 0 AptaBio Therapeutics generally moves in the opposite direction as compared to the market. If AptaBio Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one AptaBio Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of AptaBio Therapeutics is generally in the same direction as the market. If Beta > 1 AptaBio Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
AptaBio Therapeutics November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of AptaBio Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AptaBio Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of AptaBio Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing AptaBio Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AptaBio Therapeutics's daily price indicators and compare them against related drivers.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 19.84 | |||
| Value At Risk | (7.02) | |||
| Potential Upside | 6.16 |
Complementary Tools for AptaBio Stock analysis
When running AptaBio Therapeutics' price analysis, check to measure AptaBio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AptaBio Therapeutics is operating at the current time. Most of AptaBio Therapeutics' value examination focuses on studying past and present price action to predict the probability of AptaBio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AptaBio Therapeutics' price. Additionally, you may evaluate how the addition of AptaBio Therapeutics to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |